How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical ...

In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...

Artificial intelligence (AI) should soon be taking a greater role in areas including patient recruitment and in building efficiencies around data quality.

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...

New data reveals sponsors risk wasting billions by designing overly complex trials and repeatedly recruiting from oversaturated investigator sites Boston, US. 9 July, 2025. Dr. Gen Li, CEO of Phesi, a ...

Substantial clinical need expected to facilitate rapid overall trial enrollmentHOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- ...

Contingency management interventions for stimulant and opioid use disorders should offer $128 per week for vouchers or $55 ...

Explore valuable tips and strategies to enhance clinical trials by prioritising and improving the overall patient experience. Learn how to optimise patient recruitment, retention, and satisfaction ...

Focusing on trial design with patient-centred insights and involving them in the process helps provide sponsors a more holistic view of what is needed to improve patient recruitment and engagement ...